Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Conditions:   Healthy Volunteer;   Prostate Cancer;   Head and Neck Cancer;   Esophageal Cancer;   Genitourinary Cancer;   Sarcoma;   Breast Cancer;   Colon Cancer;   Gastrointestinal Cancer;   Solid Tumor Cancer;   Lung Cancer;   Skin Cancer;   Melanoma
Intervention:  
Sponsors:   Washington University School of Medicine;   Roche Sequencing Solutions;   Barnes Jewish Health Foundation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 22, 2020 / by / in
Comments